Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TMDX
#1134
TransMedics Group, Inc. Common Stock
145.2
6
+10.61%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+10.61%
Monthly Change
+4.48%
6 month change
+22.71%
Year Change
+95.03%
Previous Close
131.3
3
Open
145.2
6
Bid
Ask
Low
145.2
6
High
145.2
6
Volume
83
Markets
US Stock Market
Healthcare
TMDX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.18 M
27.96 M
32.2 M
32.72 M
33.66 M
34.3 M
—
Valuation ratios
Enterprise value
520.08 M
510.17 M
1.64 B
2.12 B
1.76 B
3.68 B
13.19 B
Price to earnings ratio
—
-11.97
-46.43
-99.74
61.73
24.98
189.31
Price to sales ratio
—
17.49
18.06
10.34
4.97
8.15
30.43
Price to cash flow ratio
—
-18.33
-36.84
-191.69
44.99
25.57
143.38
Price to book ratio
—
7.8
9.01
18.2
9.61
10.42
21.88
Enterprise value to EBITDA ratio
-20.97
-13.56
-58.57
-103.05
30.78
27.14
122.98
Profitability ratios
Return on assets %
0.19
0.33
0.13
0.04
0.04
0.18
0.19
Return on equity %
0.28
0.65
0.19
0.18
0.16
0.4
0.5
Return on invested capital %
671.93
483.41
306.8
66.23
43.32
21.29
23.53
Gross margin %
64.88
69.92
69.84
63.77
59.36
59.92
239.76
Operating margin %
102.91
130.29
33.64
11.89
8.49
17.93
71.79
EBITDA margin %
-96.75
-124.28
-29.92
-8.5
12.97
22.42
89.75
Net margin %
112.13
146.06
38.73
10.35
8.03
31.43
122.53
Liquidity ratios
Quick ratio
11.35
4.47
9.79
8.49
7.52
6.59
31.21
Current ratio
12.36
5.11
10.66
9.3
8.3
7.14
33.79
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.2
0.21
0.45
0.49
0.58
0.65
0.67
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.23
0.26
0.21
0.72
0.63
0.47
2.19
Long term debt to total equity ratio
0.33
0.52
0.31
3.69
2.23
1.06
6.01
Per share metrics
Operating cash flow per share
—
1.05
1.55
0.4
1.39
4.76
4.75
EBIT per share
—
-1.43
-1.06
-0.88
1.06
2.68
2.69
EBITDA per share
—
-1.36
-0.95
-0.63
1.63
3.35
3.36
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.35
6.81
12.14
9.56
12.05
41.13
Net current asset value per share
—
4.3
8.54
15.7
14.12
15.73
57.21
Tangible book value per share
—
2.46
6.34
3.78
6.1
11.34
33.56
Working capital per share
—
3.46
7.74
14.01
12.42
13.53
50.26
Book value per share
—
2.46
6.34
4.22
6.49
11.67
34.9
News
TransMedics clarifies Q4 tax benefit impact on earnings
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
Needham raises TransMedics stock price target to $174 on beat
TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
TransMedics surges on earnings beat, solid guidance
Dow Jones Futures: Stock Market Bounces Before Trump Speech, Nvidia Earnings
TransMedics earnings beat by $2.23, revenue topped estimates
Investors brace for TransMedics earnings amid margin questions
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates
TMDX Wins Full FDA IDE Approval for Next-Gen OCS ENHANCE Heart Trial
DexCom (DXCM) Q4 Earnings and Revenues Top Estimates